GIBBS MICHAEL TERRENCE (General Counsel) sold 10.0% of their position (7.28K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $15.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2021ACC: 0000899243-21-007776
Officer· General Counsel
Since Jul 2018
-7.28K
Net shares
Net seller
$15.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 17.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
16.0%
2/21/2021
62.63K→72.63K
Common Stock
Direct
Shares
−7.28K
Price / share
$2.06
Trade value
$15K
% of position
10.0%
2/23/2021
72.63K→65.35K
Total
Net shares
+2.72K
Net value
-$15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2021 | M · Option Exercise | +10K | — | — | 16.0% | 62.63K | 72.63K |
| Common Stock Direct | 2/23/2021 | S · Sale | −7.28K | $2.06 | $15K | 10.0% | 72.63K | 65.35K |
| Total | +2.72K | -$15K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
Held after
10K
Exercisable
—
2/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock10K shares | 2/21/2021 | M · Option Exercise | −10K | — | 10K |